Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Aspira Women's Health Dividend Announcement
• Aspira Women's Health announced a quarterly dividend of $0.02 per ordinary share which will be made payable on 2016-12-29. Ex dividend date: 2016-12-16
• Aspira Women's Health's trailing twelve-month (TTM) dividend yield is -%
Aspira Women's Health Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2016-12-16 | $0.02 | quarterly | 2016-12-29 |
2016-09-16 | $0.02 | quarterly | 2016-09-29 |
2016-06-17 | $0.02 | quarterly | 2016-06-30 |
2016-03-18 | $0.02 | quarterly | 2016-03-31 |
2015-12-18 | $0.02 | quarterly | 2015-12-31 |
2015-09-18 | $0.02 | quarterly | 2015-10-01 |
2015-06-19 | $0.02 | quarterly | 2015-07-02 |
2015-03-20 | $0.02 | quarterly | 2015-04-02 |
2014-12-19 | $0.02 | quarterly | 2015-01-02 |
2014-09-19 | $0.02 | quarterly | 2014-10-02 |
2014-06-20 | $0.02 | quarterly | 2014-07-02 |
2014-03-21 | $0.01 | quarterly | 2014-04-03 |
2013-12-20 | $0.03 | quarterly | 2014-01-02 |
2013-09-20 | $0.03 | quarterly | 2013-10-03 |
2013-06-21 | $0.03 | quarterly | 2013-07-03 |
2013-03-01 | $0.03 | quarterly | 2013-03-12 |
2012-12-14 | $0.03 | quarterly | 2012-12-26 |
2012-09-14 | $0.03 | quarterly | 2012-09-25 |
2012-07-26 | $0.03 | quarterly | 2012-08-06 |
2012-03-28 | $0.03 | quarterly | 2012-04-06 |
2011-12-21 | $0.03 | quarterly | 2012-01-06 |
2011-09-29 | $0.03 | quarterly | 2011-10-07 |
2011-07-25 | $0.03 | quarterly | 2011-08-05 |
2010-11-10 | $0.01 | quarterly | 2010-11-26 |
2010-08-20 | $0.01 | quarterly | 2010-09-09 |
2010-05-21 | $0.01 | quarterly | 2010-06-10 |
2010-03-12 | $0.01 | quarterly | 2010-04-01 |
2009-11-20 | $0.01 | quarterly | 2009-12-10 |
2009-08-21 | $0.01 | quarterly | 2009-09-10 |
2009-05-21 | $0.01 | quarterly | 2009-06-11 |
Aspira Women's Health Dividend per year
Aspira Women's Health Dividend growth
Aspira Women's Health Dividend Yield
Aspira Women's Health current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Aspira Women's Health stock? Use our calculator to estimate your expected dividend yield:
Aspira Women's Health Financial Ratios
Aspira Women's Health Dividend FAQ
Other factors to consider when evaluating Aspira Women's Health as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Aspira Women's Health stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Aspira Women's Health's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Aspira Women's Health publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Aspira Women's Health distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Aspira Women's Health are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Aspira Women's Health sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Aspira Women's Health distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Aspira Women's Health declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Aspira Women's Health's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Aspira Women's Health's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.